PEY14 ASSESSMENT OF THE PERSISTENCE DEGREE IN PATIENTS WITH ANTIGLAUCOMA AGENTS AS FIRST LINE MONOTHERAPIES IN SPAIN
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65248-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65248-5/fulltext
Section Title :
Section Order :
405
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65248-5&doi=10.1016/S1098-3015(10)65248-5